Back to Search

NANCY LESLIE, PHD

PHD

Clinical Neuropsychologist

NPI: 1225046055Individual

Specialties, Licenses & Credentials

Clinical NeuropsychologistPrimary

Clinical Neuropsychologist

Code: 103G00000X

22746(TX)

Research & Publications (20)

Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease.
PMID 19287243·Genet Med·2009
3-trial
A novel hereditary spastic paraplegia with dystonia linked to chromosome 2q24-2q31.
PMID 19006192·Mov Disord·2009
8-other
The significance of PTEN's protein phosphatase activity.
PMID 19168090·Adv Enzyme Regul·2009
6-review
PtdIns5P protects Akt from dephosphorylation through PP2A inhibition.
PMID 19576174·Biochem Biophys Res Commun·2009
8-other
Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease.
PMID 19542901·Pediatr Res·2009
2-rct
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity.
PMID 19369943·EMBO J·2009
7-preclinical
Time for a rethink on the ban on swill feeding?
PMID 19234335·Vet Rec·2009
7-preclinical
Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect.
PMID 17975019·Mol Endocrinol·2008
7-preclinical
Understanding PTEN regulation: PIP2, polarity and protein stability.
PMID 18794881·Oncogene·2008
6-review
Use of Akt inhibitor and a drug-resistant mutant validates a critical role for protein kinase B/Akt in the insulin-dependent regulation of glucose and system A amino acid uptake.
PMID 18669636·J Biol Chem·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
8441 STATE HWY 47, STE 4600
BRYAN, TX 77807

Quick Facts

NPI
1225046055
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile